Amnestic MCI Patients’ Perspectives toward Disclosure of Amyloid PET Results in a Research Context

被引：0

作者：

Gwendolien Vanderschaeghe

Jolien Schaeverbeke

Rik Vandenberghe

Kris Dierickx

机构：

[1] KU Leuven,Centre for Biomedical Ethics and Law, Department of Public Health and Primary Care

[2] KU Leuven,Laboratory for Cognitive Neurology, Department of Neurosciences

[3] Alzheimer Research Centre KU Leuven,Memory Clinic / Neurology

[4] Leuven research Institute for Neurodegenerative Disorders,undefined

[5] University Hospitals Leuven (UZ Leuven,undefined

[6] Campus Gasthuisberg),undefined

来源：

Neuroethics | 2017年 / 10卷

关键词：

Ethics; Amnestic MCI; Clinical trial; Qualitative research; Disclosure of return of results; Individual research results; Biomarker; Amyloid PET; Belgium;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：281 / 297

页数：16

共 50 条

[21] "There has to be more caring": patient and care partner experiences of the disclosure of amyloid-β PET scan results
Couch, Elyse
Zhang, Wenhan
Belanger, Emmanuelle
Shepherd-Banigan, Megan
DePasquale, Nicole
Van Houtven, Courtney H.
Gadbois, Emily A.
Wetle, Terrie
AGING & MENTAL HEALTH, 2025, 29 (01) : 112 - 120
[22] Perspectives of Chinese Cancer Patients Toward Disclosure of Cancer Diagnosis to Their Minor Children
Wang, Qi
Arber, Anne
Shen, Aomei
Qiang, Wanmin
CANCER NURSING, 2020, 43 (01) : 2 - 11
[23] False Memory and Alzheimer's Disease Pathology in Patients with Amnestic Mild Cognitive Impairment: A Study with Amyloid PET
Choi, Eun-Ji
Kim, Bum Joon
Kim, Hyung-Ji
Kwon, Miseon
Han, Noh Eul
Lee, Sun-Mi
Jo, Sungyang
Lee, Sunju
Lee, Jae-Hong
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2021, 11 (02) : 172 - 180
[24] Predictive Scale for Amyloid PET Positivity Based on Clinical and MRI Variables in Patients with Amnestic Mild Cognitive Impairment
Chun, Min Young
Kim, Geon Ha
Park, Hee Kyung
Yang, Dong Won
Kim, SangYun
Choi, Seong Hye
Jeong, Jee Hyang
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (12)
[25] Treatment with the insulin-sensitizing PPAR-? agonist rosiglitazone preserves cognition and modulates plasma a-amyloid in patients with AD and amnestic MCI
Craft, S
Watson, GS
Baker, L
Cholerton, B
Reger, M
Plymate, S
Fishel, M
Kahn, S
INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 104 - 104
[26] "And Does That Necessarily Mean Absolutely Alzheimer's?" An Analysis of Questions Raised Following Amyloid PET Results Disclosure
Kim, Jeong Eun
Tamres, Lisa K.
Orbell, Staci L.
Cheng, Rebekah Z.
Klunk, William E.
Aizenstein, Howard J.
Butters, Meryl A.
Mcdade, Eric
Lingler, Jennifer H.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2024, 32 (01): : 45 - 54
[27] Distinct amyloid and tau PET signatures are associated with diverging clinical and imaging trajectories in patients with amnestic syndrome of the hippocampal type
Julien Lagarde
Pauline Olivieri
Matteo Tonietto
Philippe Gervais
Claude Comtat
Fabien Caillé
Michel Bottlaender
Marie Sarazin
Translational Psychiatry, 11
[28] Distinct amyloid and tau PET signatures are associated with diverging clinical and imaging trajectories in patients with amnestic syndrome of the hippocampal type
Lagarde, Julien
Olivieri, Pauline
Tonietto, Matteo
Gervais, Philippe
Comtat, Claude
Caille, Fabien
Bottlaender, Michel
Sarazin, Marie
TRANSLATIONAL PSYCHIATRY, 2021, 11 (01)
[29] Research Use of Ecological Momentary Assessment for Adverse Event Monitoring Following Amyloid-β Results Disclosure
Mattos, Meghan K.
Sereika, Susan M.
Beach, Scott R.
Kim, Hyejin
Klunk, William E.
Knox, Melissa
Nadkarni, Neelesh K.
Parker, Lisa S.
Roberts, J. Scott
Schulz, Richard
Tamres, Lisa
Lingler, Jennifer H.
JOURNAL OF ALZHEIMERS DISEASE, 2019, 71 (04) : 1071 - 1079
[30] Value of Knowing: Health-Related Behavior Changes following Amyloid PET Results Disclosure in Mild Cognitive Impairment
Wang, Y.
Ren, D.
Roberts, J. S.
Tamres, L. K.
Lingler, J. H.
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2024, 11 (04): : 958 - 965

← 1 2 3 4 5 →